Canadian Online Pharmacy

CDER New August 11, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 8, 2014


New and Generic Drug Approvals

August 7, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Angiomax bivalirudin Injectable;Intravenous Medicines Co Manufacturing Change or Addition
Axert almotriptan malate Tablet;Oral Janssen Pharms Labeling Revision
Delflex W/ Dextrose 1.5% In Plastic Container calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate Solution;Intraperitoneal Fresenius Medcl Manufacturing Change or Addition
Delflex W/ Dextrose 1.5% Low Magnesium In Plastic Container calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate Solution;Intraperitoneal Fresenius Medcl Manufacturing Change or Addition
Delflex W/ Dextrose 2.5% In Plastic Container calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate Solution;Intraperitoneal Fresenius Medcl Manufacturing Change or Addition
Delflex W/ Dextrose 2.5% Low Magnesium In Plastic Container calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate Solution;Intraperitoneal Fresenius Medcl Manufacturing Change or Addition
Delflex W/ Dextrose 4.25% In Plastic Container calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate Solution;Intraperitoneal Fresenius Medcl Manufacturing Change or Addition
Delflex W/ Dextrose 4.25% Low Magnesium In Plastic Container calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate Solution;Intraperitoneal Fresenius Medcl Manufacturing Change or Addition
Humira adalimumab Syringe Abbvie Inc Manufacturing Change or Addition
Humira adalimumab Vial Abbvie Inc Manufacturing Change or Addition
Norpramin desipramine hydrochloride Tablet;Oral Sanofi Aventis Us Manufacturing Change or Addition
Optimark gadoversetamide Injectable;Injection Mallinckrodt Labeling Revision
Optimark gadoversetamide Injectable;Injection Mallinckrodt Labeling Revision
Optimark In Plastic Container gadoversetamide Injectable;Injection Mallinckrodt Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery